Strategic expansion Primo Medical Group shows active growth through acquisitions and capacity expansion, including the acquisition of NASP’s Cleanroom Assembly and Packaging business. This indicates increasing capabilities in sterile packaging and complex assembly, presenting cross-sell opportunities for expanded outsourcing services and integrated supply chain management.

Diversified outsourcing The company offers end-to-end medical device outsourcing, including OEM distribution, engineering, precision components, finished goods assembly, device refurbishment, and reusable kit management. This breadth creates multiple upsell paths to customers seeking a single vendor for multiple stages of product lifecycle management.

Aerospace and defense crossover Primo markets precision machining for aerospace, defense, and medical devices, signaling robust quality and regulatory knowledge in high-stakes industries. This positions Primo to pursue cross-industry projects with medical device customers needing stringent standards and higher-mix, low-volume manufacturing.

Financial health cue With revenue in the range of $25M–$50M and recent strategic investments, Primo demonstrates a scalable business model. Revenue growth potential can be unlocked by targeting mid-market medical device companies seeking outsourced manufacturing and turnkey supply chain solutions.

Innovation and partnerships Past investments in early-stage ventures like Versago Vascular Access and ongoing engineering and refurbishment services indicate a collaborative approach to product development. Leverage this network for joint ventures, pilot programs, and early-access collaborations with potential customers seeking innovation partners.